MarketBeat
08 Nov 2026, 06:15 UTC · 6h ago
Molson Coors Beverage Q3 Earnings Call Highlights
Impact · against what's priced in
Molson Coors (TAP) faces a significant negative catalyst as it lowers its 2026 revenue and EPS guidance due to a combination of category softness and rising input costs. Fever-Tree (EVTNY) receives a modest positive signal from improved distribution support via its partnership with TAP.
- TAP−0.70
No priced-in read yet
- In context
The company lowered its 2026 underlying EPS forecast to a decline of 16% to 19% (from 11% to 15%) and shifted its revenue outlook from flat to a 1% to 2% decline, driven by higher aluminum and freight costs.
Read from the article alone
